Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ALLERSIN-F TABLET 4 mg - HSA Drug Approval Details

Approvals/HSA/ALLERSIN-F TABLET 4 mg

Approved

THERAPEUTIC

ALLERSIN-F TABLET 4 mg

SUNWARD PHARMACEUTICAL PRIVATE LIMITED🇸🇬 Health Sciences Authority

Approval Date: Jun 2, 1989
Approval ID: 566ab470b2c05e97
Company: SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Type: Therapeutic

Approval Details

Approval Id: 566ab470b2c05e97
Drug Name: ALLERSIN-F TABLET 4 mg
Product Name: ALLERSIN-F TABLET 4 mg
Approval Number: SIN03180P
Approval Date: 1989-06-02
Registrant: SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder: SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Pharmacy Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: R06AB02
Atc Item Name: dexchlorpheniramine
Pharma Manufacturer Name: SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path: /organization/sunward-pharmaceutical-private-limited

Active Ingredients

CHLORPHENIRAMINE MALEATE

4 mg

CHLORPHENIRAMINE MALEATE

4 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 2, 1989

Approval ID

566ab470b2c05e97

Type

Therapeutic

Back to HSA Approvals